JPH0651692B2 - Optically active compound - Google Patents

Description

DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention relates to a prostaglandin synthesis method (G.Stork, T.Takahashi, I.Kawamoto, T.) developed by G.Stork et al.
Suzuki: J. Am. Chem. Soc., 100 , 8272 (1978)), the following general formula (P) (In the general formula (P), R ¹ represents an alkyl group having 4 to 10 carbon atoms, R ² represents a hydrogen atom or an aralkyl group selected from benzyl and 4-nitrophenylmethyl, and *
Represents the asymmetric carbon atom) and is an intermediate for producing an optically active lactone derivative.

(Prior Art and Problems to be Solved) Regarding the production of prostaglandins, in addition to the synthetic method of G. Stork et al., A method starting from corey lactone or 4-hydroxycyclopentenone has been put into practical use. , This method needs to undergo steps such as optical resolution and asymmetric hydrolysis by microorganisms in order to obtain the optically active substance of the raw material,
Furthermore, there are many problems in stereocontrol at the stage of introducing α and ω side chains based on these. From this point of view, it can be said that the prostaglandin synthetic method developed by G. Stork et al. Using the optically active-lactone derivative of the general formula (P) as a key intermediate is an excellent method. However, the problem in this method depends on how economically the compound of the general formula (P), which is a key intermediate, can be produced.

(Means for Solving the Problems) As a result of intensive studies to solve the above problems, the present inventors have found that a compound represented by the above general formula (P), which is a key intermediate, can be used more simply and efficiently than before. The present invention provides a method for producing well, and the present invention provides an intermediate obtained in the process of production and a method for producing the same.

The present invention includes the following general formula (A) (In the general formula (A), R ¹ represents an alkyl group having 4 to 10 carbon atoms, R ² represents a hydrogen atom or an aralkyl group selected from benzyl and 4-nitrophenylmethyl, and *
Is a chiral carbon atom) and is an optically active compound.

Specific examples of R ¹ in the general formula (A) include butyl, isobutyl, pentyl, isopentyl, 2,2-dimethylpentyl, hexyl, 2-hexyl, heptyl, 2
-A straight-chain or branched alkyl group such as heptyl, octyl, 2-octyl, nonyl, 2-nonyl, decyl and 2-decyl can be mentioned.

Prostaglandins are compounds having extremely strong physiological activity, which are produced by the chemical conversion of higher unsaturated fatty acids such as arachidonic acid by prostaglandin synthase in vivo and have the following structures.

In natural prostaglandins, R ¹ is n-C ₅ H
₁₁ -, R is _{(CH 2)} 6 COOH or _CH 2 CH = CH
It is known that (CH ₂ ) ₃ COOH and that the substituent of R ¹ has lipophilicity is important for the expression of physiological activity. In the course of development and research as pharmaceuticals, R ¹ is preferably an alkyl group, a cycloalkyl group or an aralkyl group having 4 to 10 carbon atoms, such as pentyl, isopentyl, 2,2-dimethylpentyl,
Hexyl, 2-hexyl, heptyl, 2-ethoxy-1,
1-dimethylethyl, 5-methoxy-1-methylpentyl and other alkyl groups, cyclopentyl, 3-ethylcyclopentyl, 4-propylcyclohexyl and other cycloalkyl groups, phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2- Chlorothiophene-
It has been revealed that aralkyl groups such as 5-yloxymethyl and furan-2-yl-2-ethyl exhibit particularly strong physiological activity. The present invention provides a raw material compound capable of introducing a substituent including these organic groups, particularly a compound capable of introducing an alkyl group having 4 to 10 carbon atoms as R ¹ .

The synthetic method of the allyl alcohol derivative represented by the general formula (A) of the present invention will be described below according to the synthetic route I.
In the following, X represents a halogen atom and M represents an alkali metal.

In the above reaction, the halogen compound (1) is reacted with a strong base such as n-butyllithium, t-butyllithium, methyllithium, lithium diisopropylamide to give an acetylene compound (2), and the alkali metal acetylide is further added with these strong bases. (2 '). The compound (4) is obtained by reacting this with an optically active aldehyde (3).

The above-mentioned alkali metal acetylide (2 ′) may be prepared by isolating the acetylene compound (2) once and reacting it with a strong base again as described above. The alkali metal acetylide obtained by reacting with an amount of a strong base or more can be used as it is.
The reaction between the alkali metal acetylide and the optically active aldehyde (3) is preferably carried out at a low temperature of -78 to 0 ° C. The reaction for obtaining the compound (4) is carried out in an inert solvent such as tetrahydrofuran, diisopropyl ether or toluene.
It can be performed in the temperature range of 78 ° C to room temperature. The compound (4) obtained by this reaction is a mixture of an erythro body (B-1) and a threo body (B-2) as shown by the following chemical formula.

From this mixture, the erythro body (B-1) or the threo body (B
In order to selectively obtain -2), it can be separated by column separation or the like, but each optical isomer can be produced easily and more selectively by a chemical method as described later. An oxidant such as CrO ₃ -pyridine, dimethyl sulfoxide (DM) is added to the compound (4).
The ethynyl ketone derivative of the compound (5) can be obtained by oxidation with (SO) -acid halide or the like.

In the reaction for synthesizing the optically active ethynyl alcohol derivative (B) from the compound (5), the ethynyl alcohol derivative (B) to be obtained is the erythro body (B-1) represented by the above chemical formula, or a threo body. The reaction conditions differ depending on whether it is (B-2). That is, the erythro body (B-
In the case of the purpose 1), the compound (5) is a zinc borohydride complex (Zn (BH ₄ ) ₂ ) and the threo compound (B-
When the purpose is 2), the ethynyl alcohol derivative (B) having the desired configuration can be obtained with good selectivity by reducing with an alkali metal selectlide, for example, potassium selectride.

In order to synthesize the optically active allyl alcohol derivative (A), which is the object compound of the present invention, from the above ethynyl alcohol derivative (B), lithium aluminum hydride or the like is allowed to act on the ethynyl alcohol derivative (B) so that the triple bond is converted into a trans bond. It is performed by reducing to a heavy bond. This reaction is performed in an inert solvent such as tetrahydrofuran or dioxane.
It can be performed at a temperature of 40 to 80 ° C.

Halogen compound (1) as a starting material in the above reaction
Can be easily synthesized by reacting optically active 2,3-0-isopropylideneglyceraldehyde obtained from D-mannitol or optically active glycidol by a known method with triphenylphosphine and tetrahalomethane.

In addition, the above-mentioned optically active aldehyde (3) is obtained by the following synthetic route.
It can be synthesized according to II. In the following,
The symbols R ¹ , R ² and * have the same meanings as the symbols R ¹ , R ² and * in the general formula (A), and X and Y are each independently a hydroxyl group, an acyl group, a sulfoxy group and a halogen. Represents a group or atom selected from atoms.

The optically active mannitol is reacted with acetone in the presence of an acid catalyst to give triacetonide (a), which is partially hydrolyzed with hydrous acetic acid to give tetraol (b), which has primary and secondary hydroxyl groups separately. To triphenylphosphine-CC ₄ , acid halide-pyridine, pyridine-methanesulfonyl chloride, etc.
The acetonide (c) is obtained by converting a part or the whole of the compound with a sulfoxy group or a halogen atom. Next, this acetonide (c) is converted into a diepoxide (d) with a base, and then R ³ Mg
Br, R ³ MgBr—Cu ₂ (CN) ₂ , R ³ Li (provided that R ³ represents a group having one carbon atom less than that of R ¹ ) or lithium aluminum hydride is introduced into the R ¹ group. The hydroxyl group is reacted with R ² X ′ (X ′ is a halogen atom or a sulfoxy group) to give an acetonide (e), which is hydrolyzed to a diol (f), and then Pb (OAc) ₄
The target optically active aldehyde (3) can be obtained by oxidation with NaIO ₄ or NaIO ₄ .

The obtained optically active allyl alcohol derivative represented by the general formula (A), which is the object of the present invention, is converted to the compound (6) -unsaturated carboxylic acid derivative according to the following synthetic route III, and then prostaglandin. It can be converted into a -lactone derivative of compound (P), which is a key intermediate in gin synthesis. In the following, R ⁴ represents a lower alkyl group having 1 to 5 carbon atoms.

In the above reaction, the allyl alcohol derivative (A) is
This is heated and reacted with trialkyl orthoacetate in the presence of an acid catalyst to carry out a Johnson-Claisen rearrangement reaction to be converted to an -unsaturated carboxylic acid derivative (6). Examples of the trialkyl orthoacetate to be used include trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, tributyl orthoacetate, triheptyl orthoacetate and the like, which are used in an amount of 2 to 10 times equivalent to the allyl alcohol derivative (A), The reaction is carried out in a solvent such as toluene, xylene or mesitylene at a temperature of 130 to 180 ° C. As the acid catalyst, a Lewis acid or a Lewis acid complex (for example, BF ₃ ·.
Organic acids such as (C ₂ H ₅ ) ₂ O) and heptanoic acid are used. When the acetonide of the thus obtained -unsaturated carboxylic acid derivative (6) is ring-opened with an acid catalyst and subjected to intramolecular lactonization, it is represented by the general formula (P) which is a key intermediate in the synthesis of prostaglandins. An optically active-lactone derivative is obtained. In the hydrolysis of acetonide in this reaction, a hydrous organic acid, an alcohol such as methanol or ethanol, a mineral acid in a solvent such as acetone or dioxane, a Lewis acid or a Lewis acid complex such as BF ₃ · ether complex, CuSO ₄ or ZnSO ₄ is used. Can be performed at room temperature to 80 ° C.

The compound of the general formula (P) thus obtained is
Prostaglandins (PGE, PGF) can be derived according to the prostaglandin synthesis method of G. Stork et al. Therefore, in the optically active compound of the general formula (A) in the present invention, as the above-mentioned raw material, the configurations at the 2-position and the 6-position in the general formula (A) are both S and the configuration at the 5-position is R. Is required.

The present invention will be described below with reference to examples.

(Example) Example <Synthesis of compound (a)> 45 g of D-mannitol was added to acetone 1 and concentrated hydrochloric acid 1 m.
After stirring vigorously at room temperature for 3 days, potassium carbonate 50
g was added and the mixture was further stirred for 1 day. The solid matter was removed by suction filtration, the solvent in the filtrate was distilled off under reduced pressure, water was added to the obtained residue, and the precipitated crystals were collected by suction filtration to obtain 45 g of a crude product. This was dissolved in 20 m of ethanol by heating and then filtered, the filtrate was cooled to room temperature, and the precipitated crystals were collected by filtration, and the optically active (2R, 3R, 4R, 5R) triacetonide (a) 37.3 represented by the following chemical formula was obtained. g (yield 50%) was obtained.

¹ HNMR (CC ₄ ) δ: 1.40 (6H, S, CH ₃ × 2) 1.43 (12H, S, CH ₃ × 4) 3.7 to 4.4 (8H, m, CH ₂ , CH) <Synthesis of compound (b) > 15 g (0.05 mol) of triacetonide (a) obtained above is added to
After stirring for 3.5 hours in 40m of 0% acetic acid at 40 ° C, the mixture was rapidly concentrated at 40 ° C under reduced pressure, acetone was added to the residue, and crystallized D-mannitol (0.72g) was filtered off. Evaporation gave a syrupy product. This was recrystallized with 50 m of benzene and 8.8 g of optically active (2R, 3R, 4R, 5R) tetraol (b) represented by the following chemical formula
(Yield 80%) was obtained.

¹ HNMR (D ₂ O) δ: 1.38 (6H, s, CH ₃ × 2) 3.3 to 4.2 (8H, m, CH ₂ , CH) <Synthesis of Compounds (c) and (d)> The tetra obtained above. All (b) 15.3 g (0.069 mol),
Anhydrous pyridine 55m (0.68mol), CH ₂ C ₂ 50m
Benzoyl chloride 16m (0.138mo
l), a mixed solution of anhydrous CH ₂ C ₂ 5m was added dropwise over 15 minutes, and after the addition, the mixture was stirred at −30 ° C. for 1 hour and at room temperature for 10 hours. It was distilled off under reduced pressure. To this residue was added methanesulfonyl chloride 11.2m (0.144mol) at 0 ° C over 20 minutes, and the suspension was further stirred at room temperature for 3 days. After confirming the completion of the reaction by thin layer chromatography, the reaction mixture was mixed with 100 m of a mixed solvent of ethyl ether: hexane = 7: 3 (volume).
Was added and the yellow suspension was filtered through Celite-545,
The solvent was distilled off under reduced pressure. The brown residue obtained is converted to CH ₂ C.
Dilute with ₂ , add concentrated hydrochloric acid to acidify, and then add CH ₂ C ₂
It was extracted 3 times with. The extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure to give the optically active compound represented by the following chemical formula (2R, 3R, 4
42 g of a brown semi-solid acetonide (c) of (R, 5R) form was obtained.

(However, Ms represents a methyl sulfoxy group, and ph represents a phenyl group.) 42 g of the above acetonide (c) and 20 g of K ₂ CO ₃ were stirred in 130 m of methanol for 15 hours, and then the reaction solution was made into Celite-5.
The mixture was filtered through 45, the filtrate was concentrated under reduced pressure at 40 ° C., 30 m of a mixed solvent of ethyl ether: hexane = 7: 3 (volume) was added, the mixture was filtered again through Celite-545, and the solvent was distilled off under reduced pressure at 40 ° C. Further, a crude product was obtained by vacuum distillation. This is further recrystallized with benzene and the optically active (2S, 3R, 4R, 5S) diepoxide (d) represented by the following chemical formula is pure.
2.7 g (21% yield) was obtained.

¹ HNMR (CDC ₃ ) δ: 1.39 (6H, s, CH ₃ × 2) 2.6 to 2.9 (4H, m, CH ₂ × 2) 2.95 to 3.12 (2H, m, CH) 3.7 to 3.95 (2H, m, CH) <Synthesis of compounds (e) and (f)> Cu ₂ (CN) ₂ 320 mg, anhydrous tetrahydrofuran 100 m
64m (94m mo) of a separately prepared ether solution of n-butylmagnesium bromide having a concentration of 1.47mol.
l) was added at 0 ° C. over 5 minutes. After stirring for 5 minutes, a solution of 6.48 g of the diepoxide (d) obtained above in 50 m of anhydrous tetrahydrofuran was added dropwise at 0 ° C. with stirring over 10 minutes, and further stirred for 1 hour. After confirming the completion of the reaction by thin layer chromatography, it was decomposed with NH ₄ C and saturated saline, stirred for 30 minutes, and extracted with ethyl ether three times,
The ether layer was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and filtered, and the solvent in the filtrate was distilled off to obtain an optical activity (6
S, 7R, 8R, 9S) crude diol (e-1) was obtained.

The crude diol (e-1) obtained above was dissolved in 30 m of anhydrous tetrahydrofuran, and 0.48 g of sodium hydride was added thereto.
(1.07 mmol) of anhydrous tetrahydrofuran (100 m) was added dropwise under reflux over 15 minutes, the mixture was further stirred and refluxed for 1 hour and then cooled to 0 ° C. CD-18-crown ether-6 132 mg and benzyl bromide 9.3 m (78 mmol) were added to this suspension.
Was added at 0 ° C., and the mixture was stirred and refluxed for 4 hours. The reaction solution was concentrated under reduced pressure, decomposed with 1N hydrochloric acid and extracted with hexane three times. The extract was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. An optically active (6S, 7R, 8R, 9S) acetonide (e-2) represented by the chemical formula was obtained.

(However, Bn represents a benzyl group.) The above-mentioned acetonide (e-2) was added to 100 m of 80% acetic acid at 100 ° C.
After heating and stirring for 10 hours, the solvent was evaporated under reduced pressure, followed by extraction with ethyl ether, the extract was washed with a caustic soda aqueous solution, and the aqueous layer was further extracted with ethyl ether. The extract was washed successively with saturated aqueous sodium hydrogen carbonate and brine and dried over anhydrous magnesium sulfate. After the solvent was distilled off, the residue was purified by silica gel column chromatography (eluted with ethyl ether: hexane = 1: 4 (volume)), and the optically active (6S, 7R, 8R, 9S) diol (f) represented by the following chemical formula: 8.66 g (55% yield based on compound (d)) was obtained.

(However, Bn represents a benzyl group) ¹ HNMR (CDC ₃ ) δ: 0.88 (6H, br, CH ₃ × 2) 1.0 to 1.8 (16H, m, CH ₂ × 8) 3.4 to 3.7 (4H, m, CH) 4.46 (2H, d, J = 10.8Hz, CH) 4.62 (2H, d, J = 10.8Hz, CH) 7.30 (10H, s, C 6 H 5) < synthesis of compound (3)> obtained above 200 mg of diol (f), 60 mg of K ₂ CO ₃ and 260 mg of lead tetraacetate in 4.5 m of anhydrous benzene were added at 4 ° C. and stirred for 3 minutes. After the reaction was completed, 100 m of hexane was added, and the mixture was filtered through Celite-545, the filtrate was washed with saturated aqueous sodium hydrogen carbonate, the aqueous layer was extracted twice with hexane, the hexane layers were combined and washed with saturated brine, and then anhydrous sulfuric acid was added. It was dried with magnesium. After the solvent was distilled off, the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 2 (volume)) to obtain (S) -2-benzyloxyheptanal (3) 160 mg (yield 80%). .

(However, Bn represents a benzyl group.) ¹ HNMR (CDC ₃ ) δ: 0.87 (3H, t, J = 5.8Hz, CH ₃ ) 1.0 to 1.8 (8H, m, CH ₂ ) 3.73 (1H, dt, J = 2.2Hz, 6.2Hz, CH
) 4.51 (1H, d, J = 11.6Hz, CH) 4.65 (1H, d, J = 11.6Hz, CH) 7.34 (5H, s, C ₆ H ₅ ) 9.64 (1H, d, J = 2.2Hz) < Synthesis of Compound (4)> Chemical Formula (1) (S) -dibromide represented by 4.8g (16.8m mo
l) anhydrous tetrahydrofuran 100 m was cooled to −78 ° C., and 1.62 mol of butyllithium-hexane solution 16.4 m (26.6 mmol) was added dropwise over 10 minutes under a nitrogen atmosphere, and at −78 ° C. for another hour. Then, the mixture was stirred at room temperature for 1 hour to convert to optically active lithium acetylide (2 '), which was cooled to -78 ° C to obtain 2.41 g (4.4) of (S) -2-benzyloxyheptanal (3) obtained above. (m mol) of anhydrous tetrahydrofuran (20 m) was added dropwise, and the mixture was further stirred for 30 minutes, decomposed with an aqueous solution of ammonium chloride, extracted three times with ethyl ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and silica gel column chromatography (ethyl ether: hexane =
The compound was purified with a ratio of 1: 3 (volume) to obtain 3.81 g of a (2S, 6S) compound represented by the following chemical formula (4) (yield 64%).
This was a mixture of erythro body: threo body = 64: 36 (weight).

(However, Bn represents a benzyl group.) <Synthesis of Compound (5)> Oxalyl dichloride 0.38 m in a solution of anhydrous dimethyl sulfoxide 680 mg (8.7 mmol) in anhydrous methylene chloride 15 m.
(4.4 mmol) was added dropwise at -70 ° C over 5 minutes, and the mixture was further stirred for 10 minutes at the same temperature. The compound (4) of the erythro body: threo body = 64: 36 obtained above was 1.00 g (2.9 m
(4 mol) of anhydrous methylene chloride was added dropwise for 9 minutes at -70.
Stir at ℃. Anhydrous triethylamine 2.0m (1m
(4 mmol) was added dropwise, the temperature was gradually returned to room temperature, hexane was added, the mixture was filtered through Celite-545, and the filtrate was washed with 1N hydrochloric acid. The aqueous layer was extracted 3 times with methylene chloride, the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and silica gel column chromatography (ethyl ether: hexane = 1: 10 (volume))
The ethynyl ketone derivative (5) of (2S, 6S) body represented by the following chemical formula was obtained (550 mg, yield 55%).

(However, Bn represents a benzyl group.) ¹ HNMR (CDC ₃ ) δ: 0.86 (3H, br t, J = 7.2 Hz, C
_{H 3) 1.0~1.9 (8H, m} , CH 2) 1.38 (3H, s, CH 3) 1.47 (3H, s, CH 3) 4.02 (1H, dd, J = 5.6Hz, 8.24Hz, C
H) 4.18 (1H, dd, J = 6.4Hz, 8.24Hz, C
H) 4.42 (1H, d, J = 11.5Hz, CH) 4.70 (1H, d, J = 11.5Hz, CH) 4.86 (1H, dd, J = 5.6Hz, 6.4Hz, CH) 7.31 (5H, s, C ₆ H ₅ ) IR νmax (neat) 695, 735, 835, 1060, 1220, 1320, 1370, 1380, 145
0,1675,2200,2860,2920,3020cm ^-1 <Synthesis of Compound (B)> 550 mg (1.6 mmol) of ethynyl ketone derivative (5) of the (2S, 6S) body obtained above into 16 m of anhydrous ether At −30 ° C., a zinc borohydride-ethyl ether solution (9.6 m, 2.5 mmol) having a concentration of 0.26 mol was added dropwise under a nitrogen atmosphere over 5 minutes, and the mixture was further stirred for 30 minutes. After the reaction was completed, water and 20 N of 0.5 N hydrochloric acid were added, and the mixture was stirred at 0 ° C for 30 minutes. The aqueous layer was extracted 3 times with ethyl ether, and the extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and silica gel column chromatography (ethyl ether: hexane = 1: 3).
(2S, 5R, purified by (volume)) and represented by the following chemical formula:
6S) ethynyl alcohol derivative (B) (erythro isomer: threo isomer = 90: 10 (weight)) 349 mg was obtained (yield 63
%).

(However, Bn represents a benzyl group) ¹ HNMR (CDC ₃ ) δ: 0.87 (3H, br t, J = 7.2 Hz, CH ₃ ) 1.0 to 1.8 (8H, m, CH ₂ ) 1.36 (3H, s, CH ₃ ) 1.45 (3H, s, CH ₃ ) 3.49 (1H, dt, J = 3.8Hz, 6.4Hz, CH) 3.88 (1H, dd, J = 6.4Hz, 7.7Hz, CH) 4.12 (1H, dd, J = 6.4Hz, 7.7Hz, CH) 4.4~4.7 (1H, m, J = 1.5Hz, 3.8Hz, CH) 4.59 (2H, s, CH 2) 4.69 (1H, ddd, J = 1.5Hz, 6.4Hz 6.4H
z, CH) 7.30 (5H, s, C ₆ H ₅ ) ¹³ CNMR (CDC ₃ ) δ: 13.98, 22.54, 25.27, 25.96, 26.22, 30.06, 31.8
5, 64.16, 65.57, 69.94, 72.49, 81.50, 83.70, 84.0
0,100.31,127.83,128.40,138.21 <Synthesis of Compound (A)> A solution of the above-obtained (2S, 5R, 6S) ethynyl alcohol derivative (B) 105 mg (0.30 mmol) in anhydrous tetrahydrofuran 2m was hydrogenated. Lithium aluminum 24.1mg
(0.63 mmol) of anhydrous tetrahydrofuran (5 m) was added at 0 ° C., and the mixture was stirred and refluxed for 18 minutes. After completion of the reaction, ethyl acetate, ethanol, water, and 0.1 N hydrochloric acid were sequentially added for decomposition, and the aqueous layer was extracted twice with ethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 3 (volume)) to be represented by the following chemical formula. 80.1 mg of the (2S, 5R, 6S) allyl alcohol derivative (A) was obtained (yield 76%).

(However, Bn represents a benzyl group.) ¹ HNMR (CDC ₃ ) δ: 0.86 (3H, t, J = 5.4Hz, CH ₃ ) 1.38 (3H, s, CH ₃ ) 1.40 (3H, s, CH ₃ ) _{1.04~1.8 (8H, m, CH 2} ) 3.2~3.5 (1H, m, CH) 3.52 (1H, dd, J = 7.7Hz, 7.7Hz, CH) 4.08 (1H, dd, J = 6.4Hz, 8.0Hz , CH) ¹³ CNMR (CDC ₃ ) δ: 14.02, 22.61, 25.46, 25.92, 26.72, 29.42, 31.9
3, 69.44, 72.22, 72.56, 82.18, 127.72, 127.79, 12
8.40, 129.89, 132.47, 140.60 Using the obtained allyl alcohol derivative (A) which is the object compound of the present invention, the above-mentioned general formula (P), which is a key intermediate for prostaglandin synthesis, is used according to the following examples.
An optically active lactone derivative represented by

<Synthesis of Compound (6)> 80.1 mg (0.23 mmol) of the (2S, 5R, 6S) allyl alcohol derivative (A) obtained above, 0.15 m (0.82 mmol) of triethylorthoacetate and a catalytic amount of hepta The noic acid was reacted by heating in 3 m of xylene at 160 ° C. for 20 minutes, the xylene and the produced ethanol were distilled off under reduced pressure, and after completion of the reaction, it was decomposed with saturated aqueous sodium hydrogen carbonate. The aqueous layer was extracted twice with ethyl ether, the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure,
Purification by silica gel column chromatography (ethyl ether: hexane = 1: 10 (volume)) to obtain 65.6 mg of (1 ′S, 3S, 6S) -unsaturated ethyl carboxylate (6) represented by the following chemical formula. (Yield 68%).

(However, Bn represents a benzyl group) ¹ HNMR (CDC ₃ ) δ: 0.86 (3H, br t, J = 7.2 Hz, CH ₃ ) 1.0 to 1.8 (8H, m, CH ₂ ) 1.33 (3H, s, CH ₃ ) 1.41 (3H, s, CH ₃ ) 2.40 (1H, dd, J = 9.0Hz, 14.7Hz, C
H) 2.50 (1H, dd, J = 5.1Hz, 14.7Hz, C
H) 2.6~3.0 (1H, m, CH) 3.5~3.8 (2H, m, CH 2) 3.9~4.3 (2H, m, CH × 2) 4.09 (2H, q, J = 7.2Hz, CH 2 O) 4.31 (1H, d, J = 11.7Hz, CH ₂ C
₆ H ₅ ) 4.55 (1 H, d, J = 11.7 Hz, CH ₂ C
₆ H ₅ ) 5.2 to 5.7 (2H, m, ═CH-) 7.27 (5H, s, C ₆ H ₅ ) ¹³ CNMR (CDC ₃ ) δ: 14.00, 14.25, 22.59, 25.03, 26.30, 31.77, 35.7.
2, 36.50, 41.77, 60.32, 66.81, 69.79, 77.30, 79.7
4, 109.08, 127.28, 127.72, 128.20, 130.84, 134.4
5,139.00,171.79 <Synthesis of Compound (P)> 65 mg (0.16 mmol) of ethyl-unsaturated carboxylate (6) of the above-obtained (1'S, 3S, 6S) body, methanol 5
m, water 1.25 m and CuSO ₄ .5H ₂ O 186 mg (0.7
(5 mmol) was stirred and refluxed for 13 hours. After completion of the reaction, ethyl ether was added and the mixture was filtered through Celite-545. The filtrate was washed with saturated saline and dried over anhydrous magnesium sulfate. After the solvent was distilled off under reduced pressure, the residue was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 5 (volume)) and the (3S, 3 ′S, 4S) -lactone derivative (P) represented by the following chemical formula was obtained. 35.5 mg was obtained (69% yield).

(However, Bn represents a benzyl group) ¹ HNMR (CDC ₃ ) δ: 0.86 (3H, br t, J = 7.2 Hz, CH ₃ ) 1.0 to 1.8 (8H, m, CH ₂ ) 3.72 to 3.9 (5H, m, CH ₂ , CH) 4.4 to 4.7 (1H, m, CH) 4.36 (1H, d, J = 11.7Hz, CH ₂ ) 4.51 (1H, d, J = 11.7Hz, CH ₂ ) 5.55 (1H, dd , J = 6.7Hz, 15.4Hz, = C
H) 5.68 (1H, dd, J = 7.7Hz, 15.4Hz, = C
H) 7.29 (5H, s, C ₆ H ₅ ) ¹³ CNMR (CDC ₃ ) δ: 14.00, 22.57, 24.98, 31.69, 34.94, 41.02, 62.2
7, 70.42, 79.50, 82.60, 127.52, 127.62, 128.23, 13
5.62,138.63,176.48 (Effect of the invention) The optically active compound of the present invention is an important compound as a raw material for producing an optically active lactone derivative which is a key intermediate in the synthesis of prostaglandins. By using, the key intermediate can be produced relatively easily and efficiently.

─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. ⁵ Identification code Internal reference number FI technical display area C07D 317/30

Claims (4)

[Claims] 1. An optically active compound represented by the following general formula (A). (In the general formula (A), R ¹ represents an alkyl group having 4 to 10 carbon atoms, R ² represents a hydrogen atom or an aralkyl group selected from benzyl and 4-nitrophenylmethyl, and *
The sign of represents an asymmetric carbon atom) 2. The optically active compound according to claim 1, wherein the alkyl group is a pentyl group. 3. The aralkyl group is a benzyl group.
Alternatively, the optically active compound according to item 2. 4. The compound of formula (A) is optically active (2S, 5
The compound according to any one of claims 1 to 3, which is an R, 6S) form.